A303360 Stock Overview
Protia Inc. designs, develops, and sells diagnostic kits in South Korea.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Protia Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩2,760.00 |
| 52 Week High | ₩8,350.00 |
| 52 Week Low | ₩2,650.00 |
| Beta | 0 |
| 1 Month Change | 0.55% |
| 3 Month Change | -5.32% |
| 1 Year Change | -63.92% |
| 3 Year Change | -66.22% |
| 5 Year Change | -62.83% |
| Change since IPO | -69.33% |
Recent News & Updates
Recent updates
Shareholder Returns
| A303360 | KR Medical Equipment | KR Market | |
|---|---|---|---|
| 7D | -3.0% | 2.5% | -3.0% |
| 1Y | -63.9% | 20.7% | 0.6% |
Return vs Industry: A303360 underperformed the KR Medical Equipment industry which returned 20.7% over the past year.
Return vs Market: A303360 underperformed the KR Market which returned 0.6% over the past year.
Price Volatility
| A303360 volatility | |
|---|---|
| A303360 Average Weekly Movement | 3.7% |
| Medical Equipment Industry Average Movement | 6.3% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in KR Market | 12.0% |
| 10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A303360 has not had significant price volatility in the past 3 months.
Volatility Over Time: A303360's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | n/a | Kook Jin Lim | www.protia.co.kr |
Protia Inc. designs, develops, and sells diagnostic kits in South Korea. The company offers PROTIA Allergy-Q, an assay kit for quantitative determination of specific IgE antibodies against individual allergens in human serum using immunoblotting technique; ImmuneCheck IgG, a whole blood test kit for total IgG concentration measurement; and TriCheck-C, an in vitro diagnostic kit for the qualitative test of human chorionic gonadotropin in human urine samples for the pregnancy diagnosis. It also provides protia food iga, a chronic food intolerance test to identify the foods that do not fit, and stay healthy; anitia canine ige, a serum to identify the cause of the allergy; anicheck bovine igg, a colostrum for feeding calves.
Protia Inc. Fundamentals Summary
| A303360 fundamental statistics | |
|---|---|
| Market cap | ₩35.54b |
| Earnings (TTM) | ₩0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs A303360 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A303360 income statement (TTM) | |
|---|---|
| Revenue | ₩0 |
| Cost of Revenue | ₩0 |
| Gross Profit | ₩0 |
| Other Expenses | ₩0 |
| Earnings | ₩0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did A303360 perform over the long term?
See historical performance and comparison